| Aktie | Ticker | Breite | GCS | 2026/Q1 | 2025/Q4 | 2025/Q3 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | ||||
| 55.949.943 $ | -2.557.325 $ | +0,2 % | 4 | 58.507.268 $ | -9.418.525 $ | -5,2 % | 3 | 67.984.422 $ | -23.183.781 $ | +18,7 % | 4 | ||||
| Evolv Technologies Holdings, Inc. | EVLV | → 0 | Neutral | 27.769.500 $ | -5.094.900 $ | -15,5 % | 1 | 32.864.400 $ | -4.885.600 $ | -12,9 % | 1 | 37.750.000 $ | -22.661.193 $ | -37,5 % | 1 |
| RECURSION PHARMACEUTICALS, INC. | RXRX | → 0 | Schwach | 18.239.238 $ | -6.059.943 $ | -24,9 % | 1 | 24.299.181 $ | -4.693.485 $ | -16,2 % | 1 | 28.992.666 $ | -1.069.401 $ | -3,6 % | 1 |
| Horizon Quantum Holdings Ltd. | HQ | → 0 | 8.044.590 $ | +8.044.590 $ | 1 | ||||||||||
| Definium Therapeutics, Inc. | DFTX | → 0 | Schwach | 1.896.615 $ | +552.928 $ | +41,2 % | 1 | 1.343.687 $ | +160.560 $ | +13,6 % | 1 | 1.183.127 $ | +531.855 $ | +81,7 % | 1 |
| Roivant Sciences Ltd. | ROIV | → 0 | Schwach | 58.629 $ | +14.958 $ | +34,3 % | 1 | ||||||||
| 55.949.943 $ | -2.557.325 $ | +0,2 % | 4 | 58.507.268 $ | -9.418.525 $ | -5,2 % | 3 | 67.984.422 $ | -23.183.781 $ | +18,7 % | 4 | ||||